DreamCIS

DreamCIS is a contract research organization (CRO), delivering comprehensive clinical trial services for pharmaceutical, biotechnology, and medical device industries. It provides end-to-end drug development support, from early-phase trials to post-market surveillance. Core capabilities include full clinical development, specialized stand-alone services, and expert consulting.

Founded in Korea in April 2000, DreamCIS addressed the growing demand for specialized clinical research. The company rapidly established itself with reliable services, accelerating new treatment development. While founder details remain private, its inception built a robust clinical trial infrastructure, quickly becoming a key regional player.

DreamCIS partners with pharmaceutical, biotechnology, and medical device firms, offering vital support for clinical development pipelines. Its mission is to advance medical innovation through rigorous, efficient clinical research, contributing new healthcare solutions. The company envisions itself as a trusted global partner, upholding quality and integrity in drug development.